Atlas Trials

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Clinical trial NCT01864174 · COMPLETED

Trial details

NCT number
NCT01864174
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2013-06-20
Primary completion
2016-06-01
Enrollment
1736

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.